Current Report · Items 5.03, 8.01, 9.01 · 8-K
MITESCO INC
MITIOTCEQUITYCurrent
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On November 5, 2026, the Board of Directors (the “Board”) approved via unanimous written consent an amendment to the Company’s Articles of Incorporation to increase the total shares of Common Stock the Company is authorized to issue from five hundred million (500,000,000) to one billion (1,000,000,000), with a par…
Company context
Mitesco, Inc. (the “Company,” “we,” “us,” or “our”) was formed in the state of Delaware on January 18, 2012. On December 9, 2015, we restructured our operations and acquired Newco4pharmacy, LLC, a development stage company which sought to acquire compounding pharmacy businesses. As a part of the restructuring, we shut down our former business line. On April 24, 2020, we changed our name to Mitesco, Inc. In October 2023, the Company changed its domicile from Delaware to Nevada in order to effect reduced costs.
Current securities
Historical securities (7)
Recent company filings
- PRE 14C filingNov 20, 2026
- NT 10-Q filingNov 16, 2026
- Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other EventsNov 6, 2026
- Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsOct 28, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsOct 13, 2026